MedPath

M.D. ANDERSON CANCER CENTER

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2.9k

Active:466
Completed:1180

Trial Phases

6 Phases

Early Phase 1:76
Phase 1:723
Phase 2:1005
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2400 trials with phase data)• Click on a phase to view related trials

Phase 2
1005 (41.9%)
Phase 1
723 (30.1%)
Not Applicable
465 (19.4%)
Phase 3
102 (4.3%)
Early Phase 1
76 (3.2%)
Phase 4
29 (1.2%)

Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHD

Not yet recruiting
Conditions
Chronic Graft Versus Host Disease
First Posted Date
2025-08-17
Last Posted Date
2025-08-17
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
8
Registration Number
NCT07127926
Locations
🇺🇸

The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States

Phase 1, Single-site, Single-arm, Clinical Imaging, and Blood-based Biomarker Trial Utilizing 18F-FSPG PET to Guide Therapy in Hepatocellular Carcinoma

Not Applicable
Not yet recruiting
Conditions
Hepatocellular Carcinoma
First Posted Date
2025-08-11
Last Posted Date
2025-08-11
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
60
Registration Number
NCT07116486
Locations
🇺🇸

The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States

iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate Cancer

Not Applicable
Not yet recruiting
Conditions
Prostate Cancer
First Posted Date
2025-08-05
Last Posted Date
2025-08-05
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
40
Registration Number
NCT07105020
Locations
🇺🇸

The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States

Facilitators and Barriers to Cancer Treatment Among Texas Residents

Not Applicable
Not yet recruiting
Conditions
Cancer
First Posted Date
2025-08-05
Last Posted Date
2025-08-05
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
120
Registration Number
NCT07105046
Locations
🇺🇸

The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States

Development and Pilot Trial of Focused ACT (FACT) for Patients With Advanced Cancer

Not Applicable
Recruiting
Conditions
Advanced Cancer
First Posted Date
2025-08-05
Last Posted Date
2025-08-05
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
70
Registration Number
NCT07105033
Locations
🇺🇸

The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 579
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.